These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28398476)

  • 1. Glycation potentiates α-synuclein-associated neurodegeneration in synucleinopathies.
    Vicente Miranda H; Szego ÉM; Oliveira LMA; Breda C; Darendelioglu E; de Oliveira RM; Ferreira DG; Gomes MA; Rott R; Oliveira M; Munari F; Enguita FJ; Simões T; Rodrigues EF; Heinrich M; Martins IC; Zamolo I; Riess O; Cordeiro C; Ponces-Freire A; Lashuel HA; Santos NC; Lopes LV; Xiang W; Jovin TM; Penque D; Engelender S; Zweckstetter M; Klucken J; Giorgini F; Quintas A; Outeiro TF
    Brain; 2017 May; 140(5):1399-1419. PubMed ID: 28398476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular models of alpha-synuclein toxicity and aggregation.
    Delenclos M; Burgess JD; Lamprokostopoulou A; Outeiro TF; Vekrellis K; McLean PJ
    J Neurochem; 2019 Sep; 150(5):566-576. PubMed ID: 31265132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.
    Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A
    Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glial α-synuclein promotes neurodegeneration characterized by a distinct transcriptional program in vivo.
    Olsen AL; Feany MB
    Glia; 2019 Oct; 67(10):1933-1957. PubMed ID: 31267577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hsp27 reduces glycation-induced toxicity and aggregation of alpha-synuclein.
    Vicente Miranda H; Chegão A; Oliveira MS; Fernandes Gomes B; Enguita FJ; Outeiro TF
    FASEB J; 2020 May; 34(5):6718-6728. PubMed ID: 32259355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.
    Collier TJ; Srivastava KR; Justman C; Grammatopoulous T; Hutter-Paier B; Prokesch M; Havas D; Rochet JC; Liu F; Jock K; de Oliveira P; Stirtz GL; Dettmer U; Sortwell CE; Feany MB; Lansbury P; Lapidus L; Paumier KL
    Neurobiol Dis; 2017 Oct; 106():191-204. PubMed ID: 28711409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, function and toxicity of alpha-synuclein: the Bermuda triangle in synucleinopathies.
    Villar-Piqué A; Lopes da Fonseca T; Outeiro TF
    J Neurochem; 2016 Oct; 139 Suppl 1():240-255. PubMed ID: 26190401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seeking a mechanism for the toxicity of oligomeric α-synuclein.
    Roberts HL; Brown DR
    Biomolecules; 2015 Mar; 5(2):282-305. PubMed ID: 25816357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity in gut microbiota drive polyphenol metabolism that influences α-synuclein misfolding and toxicity.
    Ho L; Zhao D; Ono K; Ruan K; Mogno I; Tsuji M; Carry E; Brathwaite J; Sims S; Frolinger T; Westfall S; Mazzola P; Wu Q; Hao K; Lloyd TE; Simon JE; Faith J; Pasinetti GM
    J Nutr Biochem; 2019 Feb; 64():170-181. PubMed ID: 30530257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.
    Mazzulli JR; Zunke F; Tsunemi T; Toker NJ; Jeon S; Burbulla LF; Patnaik S; Sidransky E; Marugan JJ; Sue CM; Krainc D
    J Neurosci; 2016 Jul; 36(29):7693-706. PubMed ID: 27445146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and models of alpha-synuclein-related neurodegeneration.
    Springer W; Kahle PJ
    Curr Neurol Neurosci Rep; 2006 Sep; 6(5):432-6. PubMed ID: 16928354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of α-synuclein truncation in aggregation and disease.
    Sorrentino ZA; Giasson BI
    J Biol Chem; 2020 Jul; 295(30):10224-10244. PubMed ID: 32424039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein misfolding and neurodegenerative diseases.
    Uversky VN
    Curr Protein Pept Sci; 2008 Oct; 9(5):507-40. PubMed ID: 18855701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.
    Levine PM; Galesic A; Balana AT; Mahul-Mellier AL; Navarro MX; De Leon CA; Lashuel HA; Pratt MR
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1511-1519. PubMed ID: 30651314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral mimetic priming enhances α-synuclein-induced degeneration: Implications for Parkinson's disease.
    Olsen LK; Cairns AG; Ådén J; Moriarty N; Cabre S; Alamilla VR; Almqvist F; Dowd E; McKernan DP
    Brain Behav Immun; 2019 Aug; 80():525-535. PubMed ID: 31029796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies.
    Prots I; Grosch J; Brazdis RM; Simmnacher K; Veber V; Havlicek S; Hannappel C; Krach F; Krumbiegel M; Schütz O; Reis A; Wrasidlo W; Galasko DR; Groemer TW; Masliah E; Schlötzer-Schrehardt U; Xiang W; Winkler J; Winner B
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7813-7818. PubMed ID: 29991596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-specific pluripotent stem cell-based Parkinson's disease models showing endogenous alpha-synuclein aggregation.
    Oh Y
    BMB Rep; 2019 Jun; 52(6):349-359. PubMed ID: 31186086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease.
    Sharma N; Rao SP; Kalivendi SV
    Free Radic Biol Med; 2019 May; 135():28-37. PubMed ID: 30796974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in α-synuclein functions, advanced glycation, and toxicity: implications for Parkinson's disease.
    Guerrero E; Vasudevaraju P; Hegde ML; Britton GB; Rao KS
    Mol Neurobiol; 2013 Apr; 47(2):525-36. PubMed ID: 22923367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-synuclein propagation: New insights from animal models.
    Dehay B; Vila M; Bezard E; Brundin P; Kordower JH
    Mov Disord; 2016 Feb; 31(2):161-8. PubMed ID: 26347034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.